1. Home
  2. STOK vs ROCK Comparison

STOK vs ROCK Comparison

Compare STOK & ROCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$32.40

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Gibraltar Industries Inc.

ROCK

Gibraltar Industries Inc.

HOLD

Current Price

$53.91

Market Cap

1.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
ROCK
Founded
2014
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.5B
IPO Year
2019
1993

Fundamental Metrics

Financial Performance
Metric
STOK
ROCK
Price
$32.40
$53.91
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
$34.50
N/A
AVG Volume (30 Days)
685.0K
426.4K
Earning Date
03-17-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.68
0.13
Revenue
$205,632,000.00
$1,383,811,000.00
Revenue This Year
$430.24
N/A
Revenue Next Year
N/A
$5.20
P/E Ratio
$44.52
$397.95
Revenue Growth
1128.17
23.49
52 Week Low
$5.35
$42.86
52 Week High
$38.69
$75.08

Technical Indicators

Market Signals
Indicator
STOK
ROCK
Relative Strength Index (RSI) 57.24 54.08
Support Level $30.33 $51.84
Resistance Level $34.47 $53.77
Average True Range (ATR) 2.02 2.22
MACD 0.32 0.07
Stochastic Oscillator 84.32 75.52

Price Performance

Historical Comparison
STOK
ROCK

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

Share on Social Networks: